BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma
- PMID: 11385690
- DOI: 10.1002/nau.1001
BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma
Abstract
The aim of this study was to use a systematic schedule, including urodynamics, to describe the rate of coexisting overactive bladder (OB) in patients with bladder outlet obstruction (BOO) caused by benign prostatic hyperplasia (BPH). We also identified differences between the patients with pure BOO compared with those with BOO combined with OB (BOO + OB). One hundred and sixty-two men referred to our clinic due to LUTS were included. Patients with a history that might affect their bladder function were excluded. After cystometry and pressure-flow studies, the patients were divided into pure BOO and BOO + OB. Of the 162 men, 55% had pure BOO. BOO + OB was found in 45%. Age, s-PSA, voided volume, and obstruction grade differed significantly between the groups. The patients with BOO + OB were older, had a higher s-PSA, voided smaller volumes, and were more obstructed. We found no differences in TRUS-volume, Q-max, IPS score, or PVR. There was a strong association between OB and BOO, the percentage of OB increasing with increased obstruction. TRUS-volume, Q-max, IPS score, and PVR did not predict whether the patients had a combined BOO + OB or not. These findings indicate that BOO is a progressive disease, which in time causes pronounced obstruction and perhaps in itself contributes to the development of OB.
Similar articles
-
Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.Urology. 2014 Dec;84(6):1461-6. doi: 10.1016/j.urology.2014.08.037. Urology. 2014. PMID: 25432841
-
Urodynamic Features and Significant Predictors of Bladder Outlet Obstruction in Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Small Prostate Volume.Urology. 2016 Mar;89:96-102. doi: 10.1016/j.urology.2015.11.027. Epub 2015 Dec 9. Urology. 2016. PMID: 26683755
-
Can urodynamic assessment of outflow obstruction predict outcome from watchful waiting?--A four-year follow-up study.Scand J Urol Nephrol. 2001 Dec;35(6):463-9. doi: 10.1080/003655901753367569. Scand J Urol Nephrol. 2001. PMID: 11848425
-
[Correlation of the factors on benign prostatic hyperplasia combined with obstruction].Zhonghua Nan Ke Xue. 2002;8(4):299-301. Zhonghua Nan Ke Xue. 2002. PMID: 12491701 Review. Chinese.
-
Noninvasive methods to evaluate bladder obstruction in men.Int Braz J Urol. 2013 Jan-Feb;39(1):4-9. doi: 10.1590/S1677-5538.IBJU.2013.01.02. Int Braz J Urol. 2013. PMID: 23489514 Review.
Cited by
-
The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.Yonsei Med J. 2010 May;51(3):432-7. doi: 10.3349/ymj.2010.51.3.432. Yonsei Med J. 2010. PMID: 20376898 Free PMC article.
-
Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life.BMC Urol. 2019 Sep 3;19(1):82. doi: 10.1186/s12894-019-0513-1. BMC Urol. 2019. PMID: 31481034 Free PMC article.
-
Overactive bladder and men: indications for anticholinergics.Curr Urol Rep. 2003 Dec;4(6):429-35. doi: 10.1007/s11934-003-0022-2. Curr Urol Rep. 2003. PMID: 14622494 Review.
-
The predictive factors of α1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM study.Urol Ann. 2017 Jul-Sep;9(3):261-267. doi: 10.4103/UA.UA_23_17. Urol Ann. 2017. PMID: 28794594 Free PMC article.
-
Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.Rev Urol. 2006 Winter;8(1):14-22. Rev Urol. 2006. PMID: 16985556 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous